Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi
JAMA Dermatol 2021 Jun 02;[EPub Ahead of Print], SJ Robertson, L Orme, R Teixeira, M Shamassi, F Newell, AM Patch, I Yeh, G Gard, J Wilmott, L Jackett, P LeBoit, A Fellowes, G MacArthur, S Fox, NK Hayward, B Bastian, R Scolyer, N Waddell, A Penington, M ShackletonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.